Atlas Trials

Pharmacodynamics Modeling to Optimize Dosage Regimens of Sulbactam in Patients With Acinetobacter Infections

Clinical trial NCT02688322 · COMPLETED

Trial details

NCT number
NCT02688322
Sponsor
Sutep Jaruratanasirikul
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Acinetobacter Infections
Start date
2014-09-01
Primary completion
2016-08-01
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.